New Vaccine May Work for DiabetesListen to the Podcast: The Medical Minute 8-6-13
A new diabetes vaccine approach shows promise by selectively neutralizing antigens while leaving the rest of the immune system unaffected.
A phase 2 study of the vaccine product (TOL-3021) has yielded some impressive findings.
John Schieszer has the latest on the story in today's Medical Minute.
http://www.renalandurologynews.com/new-vaccine-may-work-for-diabetes/article/306109/#